Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seiden

Showing results (491-500 of 978) with videos related to

Pageof 98
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2008
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patientsF Stephen Hodi, Marcus Butler, Darryl A Oble, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|November 4, 2015
Clinical Consensus Statement: Septoplasty with or without Inferior Turbinate ReductionJoseph K Han, Scott P Stringer, Richard M Rosenfeld, et al.
Cell Death and Differentiation|April 14, 1999
Cell death attenuation by 'Usurpin', a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, APO-1) receptor complexD M Rasper, J P Vaillancourt, S Hadano, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
Repurposing Romidepsin for Osteosarcoma: Screening FDA-Approved Oncology Drugs with Three-Dimensional Osteosarcoma SpheroidsEmily E Seiden, Spencer M Richardson, Leah A Everitt, et al.
Cancer Research Communications|September 15, 2025
Screening FDA-Approved Oncology Drugs with Three-Dimensional Spheroids Identifies Romidepsin as a Therapeutic Candidate for OsteosarcomaEmily E Seiden, Spencer M Richardson, Leah A Everitt, et al.
Stroke|August 25, 2021
Biomarkers of Coagulation and Inflammation in COVID-19-Associated Ischemic StrokeCharles Esenwa, Natalie T Cheng, Jorge Luna, et al.
Neoplasia (New York, N.Y.)|January 16, 2026
Dual CDK4/6-PI3K/mTOR inhibition reinforces cytostatic programs and tumor control in preclinical models of primary and metastatic osteosarcomaFarinaz Barghi, M Reza Saadatzadeh, Erika A Dobrota, et al.
BMJ Open|January 24, 2023
Protocol for validation of the Global Scales for Early Development (GSED) for children under 3 years of age in seven countriesVanessa Cavallera, Gillian Lancaster, Melissa Gladstone, et al.
Cancer Cell|November 18, 2022
Evaluation of cell-free DNA approaches for multi-cancer early detectionArash Jamshidi, Minetta C Liu, Eric A Klein, et al.
Nature|May 14, 2013
De novo mutations in histone-modifying genes in congenital heart diseaseSamir Zaidi, Murim Choi, Hiroko Wakimoto, et al.
Pageof 98

Showing results (491-500 of 978) with videos related to

Sort By:
Pageof 98
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2008
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patientsF Stephen Hodi, Marcus Butler, Darryl A Oble, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|November 4, 2015
Clinical Consensus Statement: Septoplasty with or without Inferior Turbinate ReductionJoseph K Han, Scott P Stringer, Richard M Rosenfeld, et al.
Cell Death and Differentiation|April 14, 1999
Cell death attenuation by 'Usurpin', a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, APO-1) receptor complexD M Rasper, J P Vaillancourt, S Hadano, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
Repurposing Romidepsin for Osteosarcoma: Screening FDA-Approved Oncology Drugs with Three-Dimensional Osteosarcoma SpheroidsEmily E Seiden, Spencer M Richardson, Leah A Everitt, et al.
Cancer Research Communications|September 15, 2025
Screening FDA-Approved Oncology Drugs with Three-Dimensional Spheroids Identifies Romidepsin as a Therapeutic Candidate for OsteosarcomaEmily E Seiden, Spencer M Richardson, Leah A Everitt, et al.
Stroke|August 25, 2021
Biomarkers of Coagulation and Inflammation in COVID-19-Associated Ischemic StrokeCharles Esenwa, Natalie T Cheng, Jorge Luna, et al.
Neoplasia (New York, N.Y.)|January 16, 2026
Dual CDK4/6-PI3K/mTOR inhibition reinforces cytostatic programs and tumor control in preclinical models of primary and metastatic osteosarcomaFarinaz Barghi, M Reza Saadatzadeh, Erika A Dobrota, et al.
BMJ Open|January 24, 2023
Protocol for validation of the Global Scales for Early Development (GSED) for children under 3 years of age in seven countriesVanessa Cavallera, Gillian Lancaster, Melissa Gladstone, et al.
Cancer Cell|November 18, 2022
Evaluation of cell-free DNA approaches for multi-cancer early detectionArash Jamshidi, Minetta C Liu, Eric A Klein, et al.
Nature|May 14, 2013
De novo mutations in histone-modifying genes in congenital heart diseaseSamir Zaidi, Murim Choi, Hiroko Wakimoto, et al.
Pageof 98